http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Design of Shield Blanket Near NB Port and Development of Be/Cu Joining for ITER
Fu Zhang,Elio Filippo,Jiming Chen,Weishan Kang,Youkun Fu 한국물리학회 2006 THE JOURNAL OF THE KOREAN PHYSICAL SOCIETY Vol.49 No.III
The design of two shield blanket modules near the neutral beam (NB) port was developed at Southwestern Institute of Physics (SWIP) in collaboration with the ITER International Team. Some results are given in this paper. The HIP technology for Be/Cu joining in the first wall is being qualified at SWIP and it is also introduced.
Predicting the Weed Control Efficacy of Photosynthesis Inhibitors by PPM Method
HONGJUN ZHANG,HAILAN CUI,JIMING YE,XUE LIU,XIANGJUN LI,CORNE KEMPENAAR,SHOUHUI WEI,HANWEN NI 韓國雜草學會 2009 Weed&Turfgrass Science Vol.29 No.3
The experiment was conducted in a greenhouse in Beijing, China, to determine whether weed control efficacy could be predicted based on Plant Photosynthesis Meter (PPM) values measured shortly after the application of photosynthesis inhibitors. The decrease of PPM values of the weed leaves treated with the mixture of atrazine and bentazone could be measured 1 day after treatment (DAT). The decreased extents depended on weed susceptibility and application dosage. There was significant correlation between the PPM values of the treated leaves 1 to 3 DAT and the biomass reduction 14 DAT. The experimental findings indicated that PPM values measured in early days after treatment could give reasonable prediction on weed control. The herbicide usually provided 90% control by weed biomass when PPM value was about 20 and relatively poor control when PPM value over 20.
Xinliang Zheng,Juan Feng,Jiarui Zhang,Hongna Xing,Jiming Zheng,Mingzi Wang,Yan Zong,Jintao Bai,Xinghua Li 성균관대학교(자연과학캠퍼스) 성균나노과학기술원 2016 NANO Vol.11 No.3
High-quality neodymium oxychlorides nanocrystals with cubic shape were synthesized by a nonhydrolytic thermolysis route. The morphology and crystal structure of the neodymium oxychlorides nanocubes were characterized by transmission electron microscopy at the nanoscale. Transmission electron microscope (TEM) image shows that the neodymium oxychlorides nanocrystals are nearly monodispersed with cube-like shape. X-ray diffraction (XRD) and selected area electron diffraction (SAED) patterns of numerous neodymium oxychlorides nanocubes suggest a pure crystal phase with tetragonal PbFCl matlockite structure. HRTEM image of individual neodymium oxychlorides nanocubes indicate that each nanocubes have a singlecrystalline nature with high quality. Unlike the anti-ferromagnetism of the bulk, the neodymium oxychlorides nanocubes show clearly anomalous ferromagnetic characteristic at room temperature. This finding provides a new platform for the exploration of diluted magnetic semiconductors, rare earth-based nanomaterials and so on.
Jinlin Hou,Edward Gane,Rozalina Balabanska,Wenhong Zhang,Jiming Zhang,Tien Huey Lim,Qing Xie,Chau-Ting Yeh,Sheng-Shun Yang,Xieer Liang,Piyawat Komolmit,Apinya Leerapun,Zenghui Xue,Ethan Chen,Yuchen Zh 대한간학회 2024 Clinical and Molecular Hepatology(대한간학회지) Vol.30 No.2
Background/Aims: Four-week treatment of linvencorvir (RO7049389) was generally safe and well tolerated, and showed anti-viral activity in chronic hepatitis B (CHB) patients. This study evaluated the efficacy, safety, and pharmacokinetics of 48-week treatment with linvencorvir plus standard of care (SoC) in CHB patients. Methods: This was a multicentre, non-randomized, non-controlled, open-label phase 2 study enrolling three cohorts: nucleos(t)ide analogue (NUC)-suppressed patients received linvencorvir plus NUC (Cohort A, n=32); treatment-naïve patients received linvencorvir plus NUC without (Cohort B, n=10) or with (Cohort C, n=30) pegylated interferon-α (Peg-IFN-α). Treatment duration was 48 weeks, followed by NUC alone for 24 weeks. Results: 68 patients completed the study. No patient achieved functional cure (sustained HBsAg loss and unquantifiable HBV DNA). By Week 48, 89% of treatment-naïve patients (10/10 Cohort B; 24/28 Cohort C) reached unquantifiable HBV DNA. Unquantifiable HBV RNA was achieved in 92% of patients with quantifiable baseline HBV RNA (14/15 Cohort A, 8/8 Cohort B, 22/25 Cohort C) at Week 48 along with partially sustained HBV RNA responses in treatment-naïve patients during follow-up period. Pronounced reductions in HBeAg and HBcrAg were observed in treatment-naïve patients, while HBsAg decline was only observed in Cohort C. Most adverse events were grade 1–2, and no linvencorvir-related serious adverse events were reported. Conclusions: 48-week linvencorvir plus SoC was generally safe and well tolerated, and resulted in potent HBV DNA and RNA suppression. However, 48-week linvencorvir plus NUC with or without Peg-IFN did not result in the achievement of functional cure in any patient.